INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 103 filers reported holding INHIBRX INC in Q3 2022. The put-call ratio across all filers is 34.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $95,000 | +9.2% | 5,181 | +54.2% | 0.00% | – |
| Q2 2023 | $87,000 | +112.2% | 3,360 | +51.0% | 0.00% | – |
| Q1 2023 | $41,000 | -67.5% | 2,225 | -56.6% | 0.00% | – |
| Q4 2022 | $126,000 | +869.2% | 5,124 | +592.4% | 0.00% | – |
| Q3 2022 | $13,000 | +116.7% | 740 | +34.8% | 0.00% | – |
| Q2 2022 | $6,000 | -87.2% | 549 | -73.9% | 0.00% | – |
| Q1 2022 | $47,000 | -82.5% | 2,100 | -65.9% | 0.00% | – |
| Q4 2021 | $269,000 | +169.0% | 6,153 | +104.6% | 0.00% | – |
| Q3 2021 | $100,000 | +53.8% | 3,007 | +29.8% | 0.00% | – |
| Q2 2021 | $65,000 | +182.6% | 2,316 | +103.5% | 0.00% | – |
| Q1 2021 | $23,000 | +21.1% | 1,138 | +97.6% | 0.00% | – |
| Q4 2020 | $19,000 | +171.4% | 576 | +49.6% | 0.00% | – |
| Q3 2020 | $7,000 | – | 385 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,286,435 | $31,697,758 | 8.22% |
| Perceptive Advisors | 3,313,783 | $81,651,613 | 2.29% |
| RA Capital Management | 3,853,867 | $94,959,283 | 1.93% |
| Soleus Capital Management, L.P. | 478,302 | $11,785,361 | 1.69% |
| Sofinnova Investments, Inc. | 1,110,183 | $27,354,909 | 1.62% |
| Birchview Capital, LP | 70,448 | $1,736 | 1.23% |
| VIKING GLOBAL INVESTORS LP | 6,639,199 | $163,589,863 | 0.82% |
| Meridian Wealth Advisors, LLC | 122,315 | $3,013,842 | 0.78% |
| Gyon Technologies Capital Management, LP | 44,074 | $1,085,983 | 0.41% |
| ArrowMark Colorado Holdings LLC | 1,139,337 | $28,073,264 | 0.34% |